Uterine Artery Embolization and Pelvic Floor Symptoms

NCT00827645 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2018-05-22

No results posted yet for this study

Summary

The objective of this study is to determine whether women who are already receiving treatment for their fibroids (ie. UAE) demonstrate improvement in urinary symptoms and sexual dysfunction as well.

Conditions

  • Leiomyoma
  • Incontinence
  • Prolapse

Sponsors & Collaborators

  • University of Texas Southwestern Medical Center

    lead OTHER

Principal Investigators

  • Clifford Y Wai, MD · University of Texas Southwestern Medical Center

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-01-01
Primary Completion
2013-01-01
Completion
2013-01-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00827645 on ClinicalTrials.gov